Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Telix Pharma | Sydney | Healthcare | Biotechnology & Medical Research | A$5.26B | 238.6x | -6.71 | A$15.39 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mesoblast | Sydney | Healthcare | Biotechnology & Medical Research | A$3.54B | -21.4x | -3.87 | A$2.76 | 8.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.5% Upside | Upgrade to Pro+ | |
Clarity Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | A$1.56B | -15.8x | 0.73 | A$5.01 | 19.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Race Oncology | Sydney | Healthcare | Biotechnology & Medical Research | A$700.42M | -144.4x | -1.7 | A$3.96 | -12.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.6% Upside | Upgrade to Pro+ | |
PYC Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$673.67M | -11.5x | 2.44 | A$1.14 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Immutep | Sydney | Healthcare | Biotechnology & Medical Research | A$403.66M | -6.7x | 0.33 | A$0.28 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CogState Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$398.95M | 26.1x | 0.28 | A$2.33 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.2% Downside | Upgrade to Pro+ | |
Dimerix | Sydney | Healthcare | Biotechnology & Medical Research | A$330.10M | -23.3x | -0.62 | A$0.55 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avita Medical Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$252.96M | -2.8x | 3.48 | A$1.65 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.6% Upside | Upgrade to Pro+ | |
Tetratherix | Sydney | Healthcare | Biotechnology & Medical Research | A$207.37M | -11.2x | 0.1 | A$4.15 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.2% Upside | Upgrade to Pro+ | |
Pacific Edge | Sydney | Healthcare | Biotechnology & Medical Research | A$178.52M | -5.4x | 5.31 | A$0.18 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Paradigm Biopharmaceuticals Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$148.25M | -6.2x | -0.09 | A$0.36 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LTR Pharma | Sydney | Healthcare | Biotechnology & Medical Research | A$131.21M | -14.1x | -0.65 | A$0.72 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Arovella Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$119.70M | -14.7x | -0.56 | A$0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Island Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | A$112.93M | -15.7x | -0.92 | A$0.44 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.8% Upside | Upgrade to Pro+ | |
Alterity Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$108.75M | -5.3x | -0.14 | A$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Imugene Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$103.54M | -1.1x | -0.02 | A$0.35 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Actinogen Medical | Sydney | Healthcare | Biotechnology & Medical Research | A$98.44M | -6.3x | -0.39 | A$0.03 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amplia Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$84.66M | -7.7x | -1.5 | A$0.17 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioxyne Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$82.53M | 17x | 0.14 | A$0.04 | -4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nyrada | Sydney | Healthcare | Biotechnology & Medical Research | A$76.45M | -10.1x | 0.08 | A$0.32 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Anteo Diagnostics | Sydney | Healthcare | Biotechnology & Medical Research | A$65.46M | -9.2x | -0.25 | A$0.02 | 9.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clever Culture Systems | Sydney | Healthcare | Biotechnology & Medical Research | A$63.96M | 43.8x | 0.3 | A$0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Syntara | Sydney | Healthcare | Biotechnology & Medical Research | A$60.40M | -4.2x | -0.05 | A$0.04 | 12.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Proteomics Intl Labs | Sydney | Healthcare | Biotechnology & Medical Research | A$59.74M | -6x | 0.37 | A$0.37 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tryptamine Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$59.04M | -10.5x | -0.16 | A$0.04 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neuroscientific Biopharma | Sydney | Healthcare | Biotechnology & Medical Research | A$53.21M | -12.7x | 0.04 | A$0.16 | -6.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cynata Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$52.24M | -4.8x | -0.36 | A$0.22 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Emyria | Sydney | Healthcare | Biotechnology & Medical Research | A$45.83M | -0.16 | A$0.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Prescient Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$45.22M | -4.8x | -0.55 | A$0.04 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Argenica Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$32.76M | -11.5x | 0.79 | A$0.26 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Holista CollTech Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$32.50M | 51x | 0.5 | A$0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rhythm Biosciences | Sydney | Healthcare | Biotechnology & Medical Research | A$28.08M | -6.3x | -0.14 | A$0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Noxopharm | Sydney | Healthcare | Biotechnology & Medical Research | A$26.89M | -5.3x | 0.16 | A$0.09 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IDT Australia Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$24.50M | -3.1x | 0.15 | A$0.06 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avecho Bio | Sydney | Healthcare | Biotechnology & Medical Research | A$22.21M | -6.4x | -1.08 | A$0.007 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BTC Health | Sydney | Healthcare | Biotechnology & Medical Research | A$20.17M | 5.3x | 0.02 | A$0.06 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neurotech Intl | Sydney | Healthcare | Biotechnology & Medical Research | A$18.89M | -1.8x | 0.02 | A$0.02 | 5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Algorae Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | A$16.87M | -18x | -0.31 | A$0.010 | 11.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cambium Bio | Sydney | Healthcare | Biotechnology & Medical Research | A$11.66M | A$0.51 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Invex Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$11.27M | -25.4x | -0.35 | A$0.12 | -20% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BPH Energy Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$10.96M | 1.7x | 0.07 | A$0.009 | -10.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Percheron Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$10.87M | -0.7x | 0.09 | A$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chimeric Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$9.76M | -0.5x | -0.05 | A$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Patrys Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$9.17M | -1.7x | -0.21 | A$0.002 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Invion Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$8.99M | -0.9x | 0.03 | A$0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Imagion Biosystems | Sydney | Healthcare | Biotechnology & Medical Research | A$8.62M | -2.1x | -0.05 | A$0.04 | 9.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inhalerx | Sydney | Healthcare | Biotechnology & Medical Research | A$6.19M | -4.9x | 0.1 | A$0.03 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zelira Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$4.52M | -1.2x | -0.01 | A$0.38 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vectus Biosystems | Sydney | Healthcare | Biotechnology & Medical Research | A$4M | -2.3x | -0.08 | A$0.08 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |